MedPath

Multicenter Center of Prospective Study of Combination Chemotherapy with Cetuximab In metastatic Colorectal Cancer

Phase 1
Conditions
nresectable colorectal cancer
Registration Number
JPRN-UMIN000017396
Lead Sponsor
Gastroenterological Surgery1, Hokkaido University Graduate school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
42
Inclusion Criteria

Not provided

Exclusion Criteria

1.The cases with serious drug hypersensitivity or allergy 2. Multiple primary cancers 3. The cases with symptomatic brain metastasis 4.The cases with infectious disease requiring systemic therapy 5.The cases with serious complications -Interstitial pneumonia, pulmonary fibrosis -Heart failure -Renal failure -Liver failure -Poor control diabetes mellitus -Icterus 6.Pregnant or lactating women 7.The cases judged to be unsuitable for registration

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response rate
Secondary Outcome Measures
NameTimeMethod
Resection rate, Progression free survival, Overall survival, Safety
© Copyright 2025. All Rights Reserved by MedPath